Skip to content

Clinical trials

Withdrawn Multiple Sclerosis, Relapsing-Remitting trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Withdrawn Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20082
20102
20111
20131
20142
20152
20163
20192
20211
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen5
Johns Hopkins University2
Novartis Pharmaceuticals2
Anna Tsakiri1
Banner Life Sciences LLC1
Bayer1
Cabaletta Bio1
EMD Serono1
Icahn School of Medicine at Mount Sinai1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting23
Multiple Sclerosis11
Autoimmune Diseases1
Erythema1
Fatigue1
Injection Site Reaction1
Multiple Sclerosis, Chronic Progressive1
Recurrence1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.